Harmony Biosciences
HRMY
HRMY
210 hedge funds and large institutions have $1.83B invested in Harmony Biosciences in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 85 increasing their positions, 65 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
-6
Holders Change %
-2.78%
% of All Funds
3.31%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.11%
New
34
Increased
85
Reduced
65
Closed
40
Calls
$4.37M
Puts
$9.12M
Net Calls
-$4.75M
Net Calls Change
-$398K
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
$31.4M |
| 2 |
BlackRock
New York
|
$202M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
$15.4M |
| 4 |
Man Group
London,
United Kingdom
|
$11.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$28.2M |
